Centella Asiatica (Gotu Kola)

What is it?

Centella asiatica, commonly known as gotu kola or tiger grass, is a perennial herbaceous plant from the Apiaceae family that has been used in traditional Ayurvedic and Chinese medicine for centuries to promote wound healing and cognitive function. Its dermatological potency stems from four key triterpenoid compounds: asiaticoside, madecassoside, asiatic acid, and madecassic acid — collectively known as centella's triterpene fraction. Asiaticoside and madecassoside are glycosidic prodrugs that are enzymatically converted to their active aglycone forms (asiatic acid and madecassic acid) in the skin. Asiatic acid stimulates type I collagen synthesis in dermal fibroblasts through activation of the TGF-beta/Smad signaling pathway and upregulation of procollagen mRNA expression. Madecassoside is primarily anti-inflammatory, inhibiting NF-kB nuclear translocation and reducing the production of pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha). Together, these compounds promote fibroblast proliferation, increase collagen and fibronectin deposition, enhance angiogenesis in wound beds, and strengthen the tensile strength of newly formed scar tissue. Centella also inhibits hypertrophic scar formation by modulating TGF-beta isoform ratios (decreasing TGF-beta1, increasing TGF-beta3), which shifts the wound healing response from fibrotic scarring toward regenerative remodeling. In cosmetic dermatology, centella extracts are widely used for their barrier-repair, anti-redness, and soothing properties, particularly in the Korean skincare tradition where 'cica' products have become a cornerstone category for sensitive and compromised skin.

How It Works

1. 1

   TGF-beta Collagen Activation

   Asiatic acid activates the TGF-beta/Smad pathway, stimulating fibroblast collagen synthesis independently of PDRN's A2A pathway.

2. 2

   NF-kB Inflammation Block

   Madecassoside inhibits NF-kB nuclear translocation, reducing IL-1beta, IL-6, and TNF-alpha production in inflamed tissue.

3. 3

   Scar Remodeling

   Shifts TGF-beta1/TGF-beta3 ratio to favor regenerative healing over fibrotic scarring.

4. 4

   Dual-Pathway Tissue Repair

   Combined with PDRN's A2A signaling, creates two independent collagen-stimulating channels for enhanced dermal regeneration.

Role in PDRN

Centella asiatica and PDRN represent a powerful convergence of two tissue-repair powerhouses that operate through complementary but distinct molecular pathways. PDRN activates adenosine A2A receptors on fibroblasts, stimulating proliferation, collagen synthesis, and VEGF-mediated angiogenesis — essentially providing the nucleotide raw materials and receptor signals that tell cells to build. Centella's asiatic acid activates collagen synthesis through the TGF-beta/Smad pathway, an entirely separate signaling cascade from PDRN's adenosine mechanism. This means the two ingredients stimulate collagen production through dual independent channels, potentially achieving greater collagen output than either could alone. The anti-inflammatory profiles are equally complementary: PDRN calms inflammation through A2A receptor-mediated suppression of TNF-alpha and IL-6, while madecassoside blocks NF-kB translocation directly. This dual anti-inflammatory action is particularly valuable in wound healing, post-procedure recovery, and chronic inflammatory skin conditions where a single anti-inflammatory pathway may not provide sufficient control. Centella's unique ability to modulate scar formation by shifting TGF-beta isoform ratios adds another dimension that PDRN alone does not directly address — making the combination especially relevant for acne scarring, surgical recovery, and any scenario where quality of tissue remodeling matters. For routine skincare, centella-based products can be layered freely with PDRN serums at any time of day, as both ingredients are gentle, non-irritating, and stable across a wide pH range.

Clinical Data

Centella asiatica's wound-healing efficacy has been validated in numerous clinical trials. A landmark RCT published in the International Journal of Lower Extremity Wounds (2010) demonstrated that topical centella triterpene cream significantly accelerated wound closure in chronic venous leg ulcers compared to placebo. A 2016 double-blind RCT showed that a standardized centella extract (TECA) significantly improved the appearance of hypertrophic scars and keloids over 6 months. In cosmetic dermatology, a 2012 clinical study demonstrated that 0.1% madecassoside cream significantly improved skin hydration, reduced TEWL (transepidermal water loss), and decreased erythema in subjects with sensitive skin after 4 weeks. The collagen-stimulating properties of asiatic acid have been confirmed in multiple in vitro and ex vivo studies, with one study showing a 2-fold increase in type I collagen synthesis in human dermal fibroblasts at therapeutic concentrations. When combined with PDRN, centella's complementary collagen-stimulating pathway (TGF-beta/Smad vs. A2A adenosine) suggests an additive or synergistic effect on dermal matrix regeneration, particularly relevant in post-procedure healing contexts.

Product Formats in the Wild

Common ways this ingredient is delivered in clinical and consumer products.